Send us a text

Join us is as we celebrate Kidney Cancer week with a Masterclass walk through metastatic Renal Cancer with Professor Ricky Frazer from Velindre Cancer Centre.

Ricky is a co-host of the hugely successful Immunobuddies podcast and has a vast experience in immunotherapy management.

We look at the indications for immunotherapy versus anti-VEGF TKI therapy.

Should we just accept anti-VEGF TKI monotherapy in Favourable Risk patients?

When should we try IO/IO combination versus IO/TKI combinations in the first line setting?

All this whilst Ricky looks to put John in his place!!

Enjoy

Send us a text

Join us for Part 2 of our Metastatic Endometrial Cancer special with the amazing Dr Gemma Eminowicz from University College London Hospital.

In episode 1 we looked at molecular profiling and immunotherapy.

In this episode we explore the role of;

- hormone therapy

- Antibody drug conjugates

- PARP inhibitors

Endometrial cancer is taking off in terms of new and exciting treatment options.

Gemma does an amazing job talking us through them.

Enjoy.

Send us a text

Dr Gemma Eminowicz returns for 2026!!

Join us as we discuss the metastatic endometrial cancer landscape with Simply Oncology 'friend of the show' Dr Gemma Eminowicz from University College Hospital London.

Advanced endometrial cancer is so much more than carboplatin and paclitaxel. It now has the complete range of oncological treatments;

- Chemotherapy

- Immunotherapy

- Antibody Drug Conjugates

- Hormone therapy

- Targeted therapy

- Radiotherapy

We look at how the molecular testing in endometrial cancer has shaped advanced endometrial cancer therapy.

We look at the arrival of chemo-immunotherapy in the MMRd group and now in the MMRp patient group.

In the MMR proficient group we discuss the merits of 1st line Chemo-immunotherapy versus sequencing treatment to allow potential VEGF targeted therapy.

Gemma shares her invaluable experience and helps Mike understand advanced endometrial cancer.

Enjoy!!